
If you’re considering a GLP-1 medication—or already taking one—you may have seen headlines about muscle loss. It’s a reasonable concern: when the number on the scale goes down, what exactly is your body losing?
Studies of semaglutide and tirzepatide show that weight loss includes both fat and lean mass. But lean mass and muscle are different measurements, and a decrease in lean mass does not automatically mean someone is becoming weaker. Understanding that distinction helps put the research into perspective.
Here’s what to know about GLP-1 and muscle loss, what the studies can tell us, and how to make muscle health part of your weight management plan.
Do GLP-1 Medications Cause Muscle Loss?
Weight loss during GLP-1 treatment can include some muscle loss. This concern also applies to substantial weight loss through other approaches, including calorie restriction. The amount and clinical significance can vary between individuals.
Medications such as semaglutide help reduce appetite and food intake. Tirzepatide, often discussed alongside GLP-1 medications, acts on both GIP and GLP-1 receptors. Their effects can make eating less easier, but eating less also makes it important to pay attention to nutrition.
Body composition findings alone do not establish that these medications directly damage muscle. They also cannot tell us whether a particular person has lost strength. To understand muscle health, we need to look beyond weight and consider the type of tissue lost and how the person functions.
Lean Mass vs. Muscle: What’s the Difference?
Lean mass includes skeletal muscle, but it also includes body water, organs, and other nonfat soft tissues. DXA scans—the imaging method used in many body composition studies—do not measure skeletal muscle directly.
That means a finding such as “25% of weight lost was lean mass” cannot be translated into “25% of weight lost was muscle.” It also does not mean someone lost 25% of their starting muscle mass. These distinctions matter when interpreting headlines or comparing results online.
What Does Research Show About GLP-1 and Lean Mass?
Two frequently discussed studies examined body composition in smaller groups of participants within larger weight loss trials.
| Study | Treatment and duration | Main body composition findings |
|---|---|---|
| STEP 1 exploratory analysis | Semaglutide 2.4 mg weekly for 68 weeks | Total fat mass decreased by about 19.3%, while total lean mass decreased by about 9.7% from baseline. |
| SURMOUNT-1 substudy | Tirzepatide, pooled doses, for 72 weeks | Fat mass decreased by about 33.9%, while lean mass decreased by about 10.9% from baseline. Approximately 75% of weight lost was fat and 25% was lean mass. |
These figures describe different measurements: percentage changes from starting fat or lean mass, and the proportion of total weight lost. They should not be used interchangeably.
In STEP 1, lean mass decreased in absolute terms, but its proportion of total body weight increased because fat loss was greater. In SURMOUNT-1, the approximate fat-to-lean split of weight lost was similar in the tirzepatide and placebo groups.
These studies help describe average changes. They do not predict your individual results, directly measure muscle strength, or establish which medication better preserves muscle. Their different designs and participant groups also limit comparisons between them.
Why Does Preserving Muscle Matter During Weight Loss?
Muscle helps you climb stairs, carry groceries, get out of a chair, and stay active. Maintaining strength and mobility becomes particularly important as people age, when muscle mass and strength naturally tend to decline.
Muscle also plays a role in metabolic health, including glucose use. However, muscle quantity is only part of the picture: muscle quality and physical function matter, too. A body composition measurement cannot capture all of those factors.
For your own treatment, useful questions include: Are everyday activities getting easier? Can you maintain your usual exercise routine? Are you noticing new weakness? Those observations give your healthcare provider context that a weight measurement cannot.
Who May Need Closer Attention to Muscle Health?
Older adults and people who already have low strength or limited mobility may need closer assessment. Age-related muscle loss, known as sarcopenia, can affect independence and physical function. A change on the scale alone cannot diagnose it.
Nutrition and activity also deserve attention during substantial weight loss. Tell your provider if you have difficulty eating enough, spend long periods inactive, or notice your physical abilities declining. These details can help guide a plan suited to your starting health and abilities.
How Can You Help Preserve Muscle While Taking a GLP-1?
Include Resistance Training
Resistance training asks muscles to work against a load. It can involve weights, resistance bands, or your own body weight.
General U.S. physical activity guidance recommends muscle-strengthening activities at least two days per week, covering the major muscle groups. Examples include band exercises, weightlifting, and appropriately modified bodyweight movements. Start at a manageable level and increase the challenge gradually; your provider or a qualified exercise professional can help adapt exercises for injuries or medical conditions.
Exercise can complement medication treatment. In a randomized trial involving liraglutide after an initial diet-induced weight loss, exercise-containing groups improved lean mass and fitness during weight maintenance. This supports including exercise in care, although it does not establish an identical outcome for every GLP-1 medication or patient.
Get Enough Protein and Overall Nutrition
Reduced appetite can make meeting nutritional needs harder. Include protein-containing foods such as eggs, fish, poultry, Greek yogurt, tofu, beans, or lentils in meals. If large meals feel difficult, smaller portions may be more manageable.
A 2025 joint advisory discusses individualized protein targets during GLP-1 treatment and emphasizes that protein alone is unlikely to adequately preserve muscle without strength training. There is no single protein target suitable for everyone.
Ask your provider or a registered dietitian what amount fits your needs. This is especially important if you have kidney disease, because protein recommendations depend on kidney function and treatment.
You can bring a typical day of meals to that conversation. Include familiar foods and your usual schedule so the advice is practical for your life.
Address Side Effects That Interfere With Eating
Nausea, vomiting, and other digestive symptoms can make eating and drinking difficult during treatment. Persistent symptoms deserve attention; severe vomiting or diarrhea can lead to dehydration.
Contact your prescribing provider if symptoms prevent adequate intake. They can assess medication tolerance and whether your treatment plan needs adjustment. Avoid changing your dose on your own.
Track Strength and Daily Function Alongside Weight
At follow-up visits, mention changes in ordinary activities: getting up from a chair, climbing stairs, carrying bags, or completing familiar exercises. Your provider may use functional assessments or body composition testing when appropriate.
Home smart scales estimate body composition rather than directly measuring muscle. Results vary by device and can be influenced by hydration. A single reading should not be treated as proof of muscle loss.
When Should You Talk to Your Healthcare Provider?
Contact your provider if you notice worsening weakness, reduced ability to complete everyday tasks, or ongoing difficulty eating enough. These changes warrant assessment rather than an assumption that muscle loss is the cause.
Persistent vomiting, diarrhea, or difficulty keeping fluids down also requires prompt medical advice. Your provider may review your intake, hydration, medication tolerance, and other possible explanations for your symptoms.
For a useful conversation, describe what changed and when: “I’m struggling with stairs that used to be easy” gives more information than “I think I’m losing muscle.”
Starting a Conversation About Weight Management With APSU
If you’re exploring prescription weight management, APSU’s free online medical questionnaire lets you share your health history, treatment goals, and concerns—including appetite, nutrition, or changes in strength. A licensed healthcare provider reviews your information and determines whether treatment is appropriate, with follow-up questions typically handled through written communication.
APSU supports AI-assisted text translation in 40+ languages to help users communicate across language barriers. There is no subscription fee. When prescribed treatment is provided, medication pricing includes the applicable consultation fee and shipping.
The initial questionnaire is free. Any subsequent medical evaluation is conducted by a licensed healthcare provider, with applicable consultation fees included in medication pricing when prescribed treatment is provided. Services, language support, and eligibility vary. A prescription is not guaranteed.